- Home
- BKU vs NVCR Comparison
BKU vs NVCR Comparison
Compare BKU & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKU
- NVCR
- Stock Information
- Founded
- BKU 2009
- NVCR 2000
- Country
- BKU United States
- NVCR Switzerland
- Employees
- BKU N/A
- NVCR N/A
- Industry
- BKU Savings Institutions
- NVCR Medical/Dental Instruments
- Sector
- BKU Finance
- NVCR Health Care
- Exchange
- BKU Nasdaq
- NVCR Nasdaq
- Market Cap
- BKU 2.6B
- NVCR 1.9B
- IPO Year
- BKU 2011
- NVCR 2015
- Fundamental
- Price
- BKU $37.86
- NVCR $17.77
- Analyst Decision
- BKU Hold
- NVCR Buy
- Analyst Count
- BKU 11
- NVCR 7
- Target Price
- BKU $40.55
- NVCR $32.43
- AVG Volume (30 Days)
- BKU 802.9K
- NVCR 1.5M
- Earning Date
- BKU 07-23-2025
- NVCR 07-24-2025
- Dividend Yield
- BKU 3.30%
- NVCR N/A
- EPS Growth
- BKU 38.76
- NVCR N/A
- EPS
- BKU 3.21
- NVCR N/A
- Revenue
- BKU $972,198,000.00
- NVCR $621,711,000.00
- Revenue This Year
- BKU $13.53
- NVCR $5.56
- Revenue Next Year
- BKU $6.80
- NVCR $9.19
- P/E Ratio
- BKU $11.68
- NVCR N/A
- Revenue Growth
- BKU 11.13
- NVCR 18.27
- 52 Week Low
- BKU $28.21
- NVCR $14.17
- 52 Week High
- BKU $44.45
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- BKU 67.66
- NVCR 52.02
- Support Level
- BKU $37.20
- NVCR $16.81
- Resistance Level
- BKU $38.36
- NVCR $18.70
- Average True Range (ATR)
- BKU 0.78
- NVCR 0.73
- MACD
- BKU 0.30
- NVCR 0.04
- Stochastic Oscillator
- BKU 90.36
- NVCR 62.75
About BKU BankUnited Inc.
BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.